- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02734394
UW WELL-FIT Exercise Program for Cancer Patients (WELL-FIT)
Study Overview
Detailed Description
This study is a single group pre-test post-test design.There are 4 optional measures that will be presented to participants from which they can choose to participate or not. These are presented with check boxes in the consent form. After completion of the University of Waterloo (UW) WELL-FIT program, participants will be given an option to continue with an exercise program; they will be offered the Graduate Program. Following consent of Graduate Program, repeated measures would be taken annually. At the time of consent, they will have the option to have their data used in research. At any point in their involvement of the exercise based programs, they can indicate "they no longer want to participate in the program or the data collection". Their medical care or participation in the UW WELL-FIT program will not be affected.
Procedures
- UW WELL-FIT advertisement for Grand River Regional Cancer Centre
- UW WELL-FIT brochure
- Referral Form
- Participants initial consultation and assessment
- Obtain consent for UW WELL-FIT
- Obtain Participant Information
- Completion of FACIT-F survey
- Metabolism & Body Composition - Information sheet for optional measures
- Physical Activity Survey- Godin Questionnaire
- Provide 3-Day food diary and Nutritional Assessment
Fitness assessment, exercise programming and data entry:
- Submaximal cardiovascular cycle ergometer or treadmill graded exercise test
- Muscular strength using force transducer
Body composition:
- Height, weight and waist girth
- Bioelectrical Impedance Analysis (BIA)
- Dual Energy X-ray Absorption (Optional)
- Range of motion using a goniometer
- Blood sampling (Optional)
- Design Individualized exercise program
- UW WELL-FIT - Commencement of participant in 12 week exercise program (2 x 60 minute classes)
- Post assessment (repeated pre-test assessments)
- Pre and post data are entered into database
- Summary and Feedback Report
- Graduate Program: participant selects to attend UW WELL-FIT Graduate Program
- Participants have annual reassessments in the Graduate Program
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L 3G1
- University of Waterloo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- previously diagnosed with cancer and will currently be receiving some form of treatment (chemotherapy, radiation therapy or hormonal therapy)
Exclusion Criteria:
- Physical / health factors that prohibit exercise or lack of medical clearance from physician
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cardiovascular and strength training exercise
24 sessions (~12 weeks) exercise
|
Cardiovascular and resistance exercise training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximal Exercise Test
Time Frame: 24 sessions (12 weeks)
|
Pre and post maximum workload using an electronic cycle ergometer in Watts
|
24 sessions (12 weeks)
|
|
Upper and Lower Limb Strength
Time Frame: 24 sessions (12 weeks)
|
pre and post strength in upper and lower limb muscles using a linear differential variable transducer (LVDT) measured in Newton.meters
|
24 sessions (12 weeks)
|
|
Body Mass Index
Time Frame: 24 sessions (12 weeks)
|
Pre and post body mass index (kg/m2)
|
24 sessions (12 weeks)
|
|
Percent Body Fat
Time Frame: 24 sessions (12 weeks)
|
Pre and Post percent body fat (units: %)
|
24 sessions (12 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glucose
Time Frame: 24 sessions (12 weeks)
|
measurement of blood glucose in mM
|
24 sessions (12 weeks)
|
|
Lipids
Time Frame: 24 sessions (12 weeks)
|
measurement of total cholesterol, low density lipoprotein,high density lipoprotein ( millimole per liter (mM/L)
|
24 sessions (12 weeks)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Marina Mourtzakis, PhD, University of Waterloo
- Principal Investigator: Caryl Russell, MSc, University of Waterloo
- Principal Investigator: Michael Sharratt, PhD, University of Waterloo
Study record dates
Study Major Dates
Study Start
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ORE18987-A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.